1. Home
  2. VERU vs CPSH Comparison

VERU vs CPSH Comparison

Compare VERU & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • CPSH
  • Stock Information
  • Founded
  • VERU 1971
  • CPSH 1984
  • Country
  • VERU United States
  • CPSH United States
  • Employees
  • VERU N/A
  • CPSH N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • VERU Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • VERU 54.6M
  • CPSH 51.9M
  • IPO Year
  • VERU 1990
  • CPSH 1987
  • Fundamental
  • Price
  • VERU $2.88
  • CPSH $4.16
  • Analyst Decision
  • VERU Strong Buy
  • CPSH
  • Analyst Count
  • VERU 3
  • CPSH 0
  • Target Price
  • VERU $33.33
  • CPSH N/A
  • AVG Volume (30 Days)
  • VERU 182.9K
  • CPSH 791.0K
  • Earning Date
  • VERU 12-15-2025
  • CPSH 10-29-2025
  • Dividend Yield
  • VERU N/A
  • CPSH N/A
  • EPS Growth
  • VERU N/A
  • CPSH N/A
  • EPS
  • VERU N/A
  • CPSH N/A
  • Revenue
  • VERU $16,886,419.00
  • CPSH $25,764,977.00
  • Revenue This Year
  • VERU N/A
  • CPSH N/A
  • Revenue Next Year
  • VERU N/A
  • CPSH N/A
  • P/E Ratio
  • VERU N/A
  • CPSH N/A
  • Revenue Growth
  • VERU 337.24
  • CPSH 7.46
  • 52 Week Low
  • VERU $2.64
  • CPSH $1.39
  • 52 Week High
  • VERU $14.20
  • CPSH $4.89
  • Technical
  • Relative Strength Index (RSI)
  • VERU 32.50
  • CPSH 56.62
  • Support Level
  • VERU $2.76
  • CPSH $3.75
  • Resistance Level
  • VERU $3.99
  • CPSH $4.49
  • Average True Range (ATR)
  • VERU 0.29
  • CPSH 0.36
  • MACD
  • VERU -0.17
  • CPSH 0.01
  • Stochastic Oscillator
  • VERU 11.23
  • CPSH 55.08

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: